Track 1: Types of STDs and Infectious Diseases

STDs (or STIs) are infections that can mostly be passed on to another person during sex, be it anal, oral or vaginal sex. There are different types of STDs, from very benign to malignant and harmful ones. Nearly 20 different infections are known to be transmitted through sexual contact. Most STDs affect both men and women, but in many cases the health problems they cause can be more severe for women. If a pregnant woman has an STD, it can cause serious health problems for the baby. More than 40 types of HPV can be spread sexually. If untreated, STIs can increase your risk of acquiring another STI such as HIV. Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi or parasites and can spread between individuals. There are almost 217 types of infectious diseases among them some are such as 'Common cold' include a number of distinct pathogens. Many infectious diseases, such as measles and chickenpox, can be prevented by vaccines.

Related Conferences: 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 5^th International Conference on HIV/AIDS, STDs & STIs, November 13-14, 2017 Las Vegas, USA; 4th World Congress on Infection Prevention and Control, November 13-15, 2017 Las Vegas, USA;  STI & HIV World Congress Rio de Janeiro July 9-12, 2017; 26th Annual Canadian Conference on HIV/AIDS Research – CAHR 2017, April 6-9, 2017 in Montreal, Quebec; 9th IAS Conference on HIV Science (IAS 2017) 23-26 July 2017, Paris, France; New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada; 35^th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA

Track 2: Viral, Fungal, Bacterial & Protozoan STDs

Depending on the type of disease, STDs can be spread with any type of sexual activity. STDs are most often caused by viruses and bacteria, both bacterial and viral STDs vary in their treatment. Bacterial STDs, such as gonorrhea, syphilis, and chlamydia, are often cured with antibiotics. However, viral STDs, such as HIV, HPV (genital warts), herpes, and hepatitis (the only STD that can be prevented with a vaccine), have no cure, but their symptoms can be alleviated with treatment. STDs, such as gonorrhea and syphilis, are classified as "reportable" because when diagnosed they must be reported to a proper health or government agency to prevent their spread. Gonorrhea, one of the most widespread of the STDs, is caused by the bacterium Neisseria gonorrhoeae, some strains of which are resistant to treatment by penicillin as well as the other drugs of choice. 80 percent of women and 40 percent of men diagnosed with chlamydia may not experiencesymptoms.

Related Conferences: 6th Global Bacteriology and Parasitology Annual Meeting, Sep 13-14, 2017 Singapore; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; 4^th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia; Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda; 19TH IUSTI Asia-Pacific Conference 1-3 December, 2016 Japan; 26th Conference of Asian Pacific Association for the Study of the Liver, Feb 15-19 2017 China; 15th Conference of the International Society of Travel Medicine, May 14-18, 2017 Spain

Track 3: STD Symptoms

STDs often have no signs or symptoms (asymptomatic). Understanding the risks and knowing the signs and symptoms of common STDs in men is crucial for any man who is sexually active. Female symptoms of an STD can include vaginal itching, rashes, unusual discharge, and pain, though many women have no symptoms. STDs can lead to fertility problems and an increased risk of cervical cancer if left untreated. These risks make it even more important to practice safe sex. This happens because an STI can stimulate an immune response in the genital area or cause sores, either of which might raise the risk of HIV transmission. The signs and symptoms usually disappear within a week to a month and are often mistaken for those of another viral infection. More-persistent or severe symptoms of HIV infection may not appear for 10 years or more after the initial infection.

Related Conferences: 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; 6th Global Bacteriology and Parasitology Annual Meeting, Sep 13-14, 2017 Singapore; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; Federation of Infection Societies (FIS) & Healthcare Infection Society (HIS) Conference, November 6-8, Edinburgh UK; 4th Annual Microbiology & Infectious Diseases Congress, October 2017, Singapore; The 8th International APSIC Congress meeting, February 12-15, 2017 Bangkok, Thailand; 16th Asia-Pacific Congress of Clinical Microbiology and Infection, Nov 30-Dec 03, Melbourne; STI & AIDS World  Congress, July 9-12, 2017 Brazil

Track 4: Epidemiology of STD and Infectious Diseases

Since 1993, STI epidemiology and management have evolved interactively, particularly in developing countries. Technological advances in diagnosis, screening, and treatment; evaluation and widespread implementation of new case-management algorithms; and changes in risk behaviors in response to the AIDS epidemic have all influenced the dynamic typology of STIs. Every year worldwide, there are approximately 357 million new infections of syphilis, chlamydia, gonorrhea, and trichomoniasis. A major recent advance in STI prevention is the early success of a prophylactic, monovalent human papillomavirus (HPV) type 16 vaccine, HPV vaccines may be able to help prevent genital and anal cancers in the foreseeable future.

Related Conferences: 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; 4^th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; International society for Influenza and other Respiratory virus diseases school of influenza, June 14-16, 2017 China; 6^th Asian conference on Hepatitis and AIDs, May 20-21, 2017 China; Spanish society of Clinical Microbiology and Infectious diseases 21^st congress, May 10-13, 2017 Spain; Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference (CACMID 2017), May 3-6, 2017 Canada; British HIV Association 23rd Annual Conference 2017 (BHIVA 2017), April 4-7, UK

Track 5: Syphilis and STD

Syphilis is a sexually transmitted disease (STD) that can have very serious complications when left untreated, but it is simple to cure with the right treatment. Symptoms in adults are divided into stages. These stages are primary, secondary, latent, and late syphilis. Syphilis can be spread by direct contact with a syphilis sore during vaginal, anal, or oral sex. Sores can be found on the penis, vagina, anus, in the rectum, or on the lips and in the mouth. Syphilis has been called ‘the great imitator’ because it has so many possible symptoms, many of which look like symptoms from other diseases. The painless syphilis sore that you would get after you are first infected can be confused for an ingrown hair, zipper cut, or other seemingly harmless bump. A syphilis infected baby may be born without signs or symptoms of disease. However, if not treated immediately, the baby may develop serious problems within a few weeks. Untreated babies can have health problems such as cataracts, deafness, or seizures, and can die.

Related Conferences: 5th International Congress on Bacteriology and Infectious Diseases May 25-26, 2017 Chicago, USA; 2nd International Conference on Respiratory and Pulmonary Medicine, August 6-8, 2017 London, UK; 5th International Conference on HIV/AIDS, STDs & STIs, November 13-14, 2017 Las Vegas, USA; 3rd International Conference on Retroviruses and Novel Drugs, July 27-28, 2017; Non-Communicable Diseases and Therapies, November 16- 17, 2017 Las Vegas, USA; Australasian Society For Infectious Diseases Annual Scientific Meeting 2017 (ASID 2017), March 29- April 01, 2017 Australia; British HIV Association 23rd Annual Conference 2017 (BHIVA 2017), April 4-7, UK; 6^th Asian conference on Hepatitis and AIDs, May 20-21, 2017 China; STI & AIDS World  Congress, July 9-12, 2017 Brazil; 19TH IUSTI Asia-Pacific Conference 1-3 December, 2016 Japan

Track 6: Determinants of STI transmission

Exposure of susceptibles to infected individuals can be influenced through counseling of patients to reduce early sexual debut and concurrent sexual partners, and to promote the performance of safer sexual activities, including:

·         Nonpenetrative sexual acts,

·         Consistent and correct use of condom, and

·         STI and HIV testing followed by commitment to monogamy.

Efficiency of transmission during exposure between susceptible and infectious partners can be influenced by a number of primary care physician interventions. Advising patients to use “safer sex” practices such as condom and avoidance of unprotected vaginal or anal intercourse can substantially reduce the transmission of some STI pathogens. The application of epidemiologic treatment to patients who have had a known exposure to a STI can reduce transmission presumably by treating patients either before symptoms develop or during the incubation period of the infection. Other forms of post- exposure prophylaxis have been also been used to prevent HIV infection following needle - stick, or sexual assault exposure. Finally, physicians can reduce the infectivity of some infected individuals by the use of suppressive antimicrobial therapy.

Related Conferences: 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; 4^th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan; Spanish society of Clinical Microbiology and Infectious diseases 21^st congress, May 10-13, 2017 Spain; Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference (CACMID 2017), May 3-6, 2017 Canada; British HIV Association 23rd Annual Conference 2017 (BHIVA 2017), April 4-7, UK; 6^th Asian conference on Hepatitis and AIDs, May 20-21, 2017 China; Australasian Society For Infectious Diseases Annual Scientific Meeting 2017 (ASID 2017), March 29- April 01, 2017 Australia

Track 7: STDs and Infectious Diseases in Pregnancy

Women who are pregnant can become infected with the same STDs as women who are not pregnant. Pregnancy does not provide women or their babies any additional protection against STDs. STDs can complicate the pregnancy and may have serious effects on both mother and the developing baby. STDs/STIs during pregnancy can also cause Miscarriage, Ectopic pregnancy, Preterm labor and delivery, Birth defects and Newborn death etc. Some of these problems may be seen at birth; others may not be discovered until months or years later. Testing and treating pregnant women for STDs is a vital way to prevent serious health complications to both mother and baby that may otherwise happen with infection. STDs, such as chlamydia, gonorrhea, syphilis, trichomoniasis and BV can all be treated and cured with antibiotics that are safe to take during pregnancy.

Related Conferences: 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; 4^th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; International society for Influenza and other Respiratory virus diseases school of influenza, June 14-16, 2017 China; Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference (CACMID 2017), May 3-6, 2017 Canada; British HIV Association 23rd Annual Conference 2017 (BHIVA 2017), April 4-7, UK; 6^th Asian conference on Hepatitis and AIDs, May 20-21, 2017 China; Spanish society of Clinical Microbiology and Infectious diseases 21^st congress, May 10-13, 2017 Spain

Track 8: STI Syndromes

The syndromic approach is an important tool in the control of STIs and their sequelae, management by syndrome alone is inadequate because infections with important pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae may be present without any symptoms or findings. It is crucial to recognize syndromes that may be caused by one or more sexually transmitted pathogens and in managing STIs, diagnosis by syndrome and laboratory diagnosis by testing for specific organisms are both important and complementary. Diagnosis of a syndrome according to standard criteria predicts the likelihood that a specific pathogen or pathogens is/are present and thus facilitates initiation of appropriate empiric treatment at the first visit rather than deferring treatment until there is microbiological confirmation. WHO has developed simple flowcharts (also called algorithms) to guide health care providers in using the syndromic approach to manage seven syndromes.

Related Conferences: 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 6th Global Bacteriology and Parasitology Annual Meeting, Sep 13-14, 2017 Singapore; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; The 8th International APSIC Congress meeting, February 12-15, 2017 Bangkok, Thailand; 16th Asia-Pacific Congress of Clinical Microbiology and Infection, Nov 30-Dec 03, Melbourne; STI & AIDS World  Congress, July 9-12, 2017 Brazil; Federation of Infection Societies (FIS) & Healthcare Infection Society (HIS) Conference, November 6-8, Edinburgh UK; 4th Annual Microbiology & Infectious Diseases Congress, October 2017, Singapore

Track 9: Birth Defects in STD

Abnormal development of the fetus resulting in death, malformation, growth retardation, and functional disorders is defined as birth defects. Approximately 150,000 babies are born each year with birth defects. Birth defects, including low birth weight babies, are the leading cause of infant mortality. Chlamydia, among the most common sexually transmitted diseases, affects an estimated 100,000 pregnant women each year, according to the Centers for Disease Control and Prevention. In fact, it's one of the leading causes of infections affecting newborns' eyes and respiratory system. Exposure to the bacteria during childbirth could lead to infection of the respiratory tract, causing infant pneumonia. While some types of birth defects have decreased, mainly through preventive methods, many have increased. According to a CDC study of 38 types of birth defects occurring over the period 1979-89, 27 had increased, including several cardiac defects, chromosomal defects such as trisomy 18, and fetal alcohol syndrome; 9 had remained the same; and only 2 had decreased.

Related Conferences: 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 5^th International Conference on HIV/AIDS, STDs & STIs, November 13-14, 2017 Las Vegas, USA; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 4th World Congress on Infection Prevention and Control, November 13-15, 2017 Las Vegas, USA;  STI & HIV World Congress Rio de Janeiro July 9-12, 2017; 26th Annual Canadian Conference on HIV/AIDS Research – CAHR 2017, April 6-9, 2017 in Montreal, Quebec; 35^th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA; 9th IAS Conference on HIV Science (IAS 2017) 23-26 July 2017, Paris, France; New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada

Track 10: STD and related Cancers

Having an STD/STI increases a person's risk for several types of cancer. Certain high-risk types of human papillomavirus (HPV) can cause cervical cancer in women and other cancers including cancer of the vulva, vagina. In men, HPV infection can lead to the development of penile cancers. HPV also can cause cancers of the mouth, throat, and anus in both sexes. It can also cause oropharyngeal cancer. Acquiring viral hepatitis B or C puts a person at risk for liver cancer, and untreated HIV/AIDS increases risk for several types of rare cancers, including lymphomas, sarcomas, and cervical cancer. There are HPV tests that can be used to screen for cervical cancer. These tests are recommended for screening only in women aged 30 years and older. They are not recommended to screen men, adolescents, or women under the age of 30 years.

Related Conferences: 4^th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; International society for Influenza and other Respiratory virus diseases school of influenza, June 14-16, 2017 China; British HIV Association 23rd Annual Conference 2017 (BHIVA 2017), April 4-7, UK; 6^th Asian conference on Hepatitis and AIDs, May 20-21, 2017 China; Spanish society of Clinical Microbiology and Infectious diseases 21^st congress, May 10-13, 2017 Spain; Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference (CACMID 2017), May 3-6, 2017 Canada

Track 11: Public Awareness on STD

Sexually transmitted Infections (STIs) rank among the most important health issues for the people especially the young adults worldwide. The development of educational programs will play vital role in the fight to control sexually transmitted diseases. The Sexually Transmitted Disease (STD) infection prevention and control program works to reduce the incidence of sexually transmitted diseases. Social media practices to help implement awareness strategies. Awareness was generally high for HIV/AIDS (above 90%) and low for HPV (range 5.4%-66%). By providing screening, testing, diagnosis and treatment for infected individuals, the STD program is fighting the war against sexually transmitted diseases one person at a time. STDs can be simply prevented with three actions (a) Talk openly to partners, patients, and healthcare providers about sexual health and STDs, (b) Ensure everyone knows who should be tested and when, (c) The important role healthcare providers and patients play in making sure STDs are treated correctly.

Related Conferences: 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 6th Global Bacteriology and Parasitology Annual Meeting, Sep 13-14, 2017 Singapore; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; The 8th International APSIC Congress meeting, February 12-15, 2017 Bangkok, Thailand; 16th Asia-Pacific Congress of Clinical Microbiology and Infection, Nov 30-Dec 03, Melbourne; STI & AIDS World  Congress, July 9-12, 2017 Brazil; Federation of Infection Societies (FIS) & Healthcare Infection Society (HIS) Conference, November 6-8, Edinburgh UK; 4th Annual Microbiology & Infectious Diseases Congress, October 2017, Singapore

Track 12: Global Market Trends in STD and Infectious Diseases

Sexually transmitted diseases(STDs) remain a major public health challenge in the world. Biological factors place women at greater risk than men for the severe health consequences of STDs. The two most commonly reported infectious diseases in America is chlamydia and gonorrhea which pose a particular risk to the health of women, as both can result in infertility if left untreated. Trends of STD are more toward viral origin as compare to bacterial origin. Epidemiology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences.

Related Conferences: 5th International Conference on HIV/AIDS, STDs & STIs, November 13-14, 2017 Las Vegas, USA; 3rd International Conference on Retroviruses and Novel Drugs, July 27-28, 2017; 5th International Congress on Bacteriology and Infectious Diseases May 25-26, 2017 Chicago, USA; 2nd International Conference on Respiratory and Pulmonary Medicine, August 6-8, 2017 London, UK; Non-Communicable Diseases and Therapies, November 16- 17, 2017 Las Vegas, USA; 6^th Asian conference on Hepatitis and AIDs, May 20-21, 2017 China; STI & AIDS World  Congress, July 9-12, 2017 Brazil; 19TH IUSTI Asia-Pacific Conference 1-3 December, 2016 Japan; Australasian Society For Infectious Diseases Annual Scientific Meeting 2017 (ASID 2017), March 29- April 01, 2017 Australia; British HIV Association 23rd Annual Conference 2017 (BHIVA 2017), April 4-7, UK

Track 13: Tuberculosis and Hepatitis

Most healthy people’s immune systems kill or contain TB infection without developing symptoms. Latent TB infection is an asymptomatic and non-transmissible form of TB. Hepatitis is an inflammation of the liver. There are 5 main hepatitis viruses, referred to as types A, B, C, D and E. Twin studies of tuberculosis (TB) and chronic hepatitis B virus (HBV) infection identified a strong host genetic component to individual variability in disease susceptibility. Short-course chemotherapy containing rifampicin and isoniazid in combination has proved to be highly effective in the treatment of tuberculosis, but one of its adverse effects is hepatotoxicity. An estimated 49 million lives were saved through TB diagnosis and treatment between 2000 and 2015.

Related Conferences: 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 6th Global Bacteriology and Parasitology Annual Meeting, Sep 13-14, 2017 Singapore; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; International society for Influenza and other Respiratory virus diseases school of influenza, June 14-16, 2017 China; British HIV Association 23rd Annual Conference 2017 (BHIVA 2017), April 4-7, UK; 6^th Asian conference on Hepatitis and AIDs, May 20-21, 2017 China; Spanish society of Clinical Microbiology and Infectious diseases 21^st congress, May 10-13, 2017 Spain; Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference (CACMID 2017), May 3-6, 2017 Canada

Track 14: Infectious Diseases and STD prevention and control

Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. STI control efforts have increasingly been defined in relation to HIV programme priorities that are funded, implemented and evaluated independently of other STI control efforts. STI control is a public health outcome, measured as reduced incidence and prevalence, achieved by implementing strategies composed of multiple synergistic interventions.

Related Conferences: 5th International Congress on Bacteriology and Infectious Diseases May 25-26, 2017 Chicago, USA; 2nd International Conference on Respiratory and Pulmonary Medicine, August 6-8, 2017 London, UK; 5th International Conference on HIV/AIDS, STDs & STIs, November 13-14, 2017 Las Vegas, USA; 3rd International Conference on Retroviruses and Novel Drugs, July 27-28, 2017; Non-Communicable Diseases and Therapies, November 16- 17, 2017 Las Vegas, USA; STI & HIV World Congress Rio de Janeiro July 9-12, 2017; 26th Annual Canadian Conference on HIV/AIDS Research – CAHR 2017, April 6-9, 2017 in Montreal, Quebec; 9th IAS Conference on HIV Science (IAS 2017) 23-26 July 2017, Paris, France; New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada; 35^th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA

Track 15: Vaccines for STD and Infectious Diseases

Some STDs, such as such as gonorrhea, Chlamydia, and syphilis, are caused by bacteria. They are usually effectively treated with antibiotics. Several STDs can be effectively prevented through pre-exposure vaccination with widely available vaccines, including HAV, HBV, and HPV. Viral STDs are often highly persistent despite current therapeutic options or have no acceptable treatment available. Therefore, vaccines for certain viral STDs are in use, and others are in development.

Related Conferences: 6th Global Bacteriology and Parasitology Annual Meeting, Sep 13-14, 2017 Singapore; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; 4^th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; The 8th International APSIC Congress meeting, February 12-15, 2017 Bangkok, Thailand; 16th Asia-Pacific Congress of Clinical Microbiology and Infection, Nov 30-Dec 03, Melbourne; STI & AIDS World  Congress, July 9-12, 2017 Brazil; Federation of Infection Societies (FIS) & Healthcare Infection Society (HIS) Conference, November 6-8, Edinburgh UK; 4th Annual Microbiology & Infectious Diseases Congress, October 2017, Singapore

Track 16: Trending Techniques involved in STDs

With the newer diagnostic technologies, we are on the verge of a major change in the approach to STI control. When diagnostic methods are faster and results more accurate, they are bound to improve patient care. The molecular techniques are useful for microorganisms that are difficult to culture. They have a fairly recent history of just over 40 years. They are increasingly being accepted by clinicians as viable options in their practice. Aseptic technique is normally applied to prevent the infections caused by different means.

Related Conferences: 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 4^th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; Spanish society of Clinical Microbiology and Infectious diseases 21^st congress, May 10-13, 2017 Spain; Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference (CACMID 2017), May 3-6, 2017 Canada; International society for Influenza and other Respiratory virus diseases school of influenza, June 14-16, 2017 China; British HIV Association 23rd Annual Conference 2017 (BHIVA 2017), April 4-7, UK; 6^th Asian conference on Hepatitis and AIDs, May 20-21, 2017 China

Track 17: STD Testing

The sexually transmitted diseases Testing Market is forecast to reach $167.4 billion by 2020, registering a CAGR of 8.5% during 2014-2020. STDs are a grave issue globally, and are responsible for high morbidity in adults and cause infertility in both men and women. Diagnostic procedures of STDs market include the technologies that are used to identify and analyze STD along with the laboratories where the tests are carried out. Diagnostic testing programs are implemented by health care departments in developed regions for prevention and control of transmission, specifically of P&S Syphilis, Chlamydia, Gonorrhea and HPV. HPV testing volume and revenue will grow at much faster rate owing to higher incidences in Asia Pacific region.

Related Conferences: 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 4th World Congress on Infection Prevention and Control, November 13-15, 2017 Las Vegas, USA; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 5^th International Conference on HIV/AIDS, STDs & STIs, November 13-14, 2017 Las Vegas, USA; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 35^th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA; 9th IAS Conference on HIV Science (IAS 2017) 23-26 July 2017, Paris, France; New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada; STI & HIV World Congress Rio de Janeiro July 9-12, 2017; 26th Annual Canadian Conference on HIV/AIDS Research – CAHR 2017, April 6-9, 2017 Montreal, Quebec

Track 18: Diagnosis and Treatment of STD, Infectious Diseases

HIV infection can be diagnosed by serologic tests that detect antibodies against HIV-1 and HIV-2 and by virologic tests that can detect HIV antigens or ribonucleic acid (RNA).Treatment for STDs should be screened for HIV infection. Women should be screened annually for cervical cancer precursor lesions by cervical Pap tests. Gonorrhea and chlamydia are bacterial STDs/STIs that can be treated with antibiotics given either orally or by injection. Successful treatment for cancroid cures the infection, resolves the clinical symptoms, and prevents transmission to others.

Related Conferences: 5^th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy; 2^nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA; 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK; 4^th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; International society for Influenza and other Respiratory virus diseases school of influenza, June 14-16, 2017 China; Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference (CACMID 2017), May 3-6, 2017 Canada; British HIV Association 23rd Annual Conference 2017 (BHIVA 2017), April 4-7, UK; 6^th Asian conference on Hepatitis and AIDs, May 20-21, 2017 China; Spanish society of Clinical Microbiology and Infectious diseases 21^st congress, May 10-13, 2017 Spain

Market analysis

More recently, several countries in Asia have documented large reductions in common STIs. Thailand measured a 95% drop in common curable STIs during the 1990s following introduction of the 100% condom use programme implemented by STI clinic staff working with sex work establishments. The largest increase in reported STD cases between 2014 to 2015 occurred in P&S syphilis (19 percent), followed by gonorrhea (13 percent) and chlamydia (6 percent). AIDS is among the leading causes of death in present-day Sub-Saharan Africa. The highest rates are found in Asia and Africa and lower rates are in the Americas and Europe.

According to the WHO, there are 340 million new cases of syphilis, gonorrhea, chlamydiasis and trichomoniasis in the 15–49 age group. HPV infections constitute 5,00,000 cases/year of which 80% are reportedly from developing countries. Every year, around 300,000 cervical cancer deaths are registered due to HPV. The same data show approximately 1,370,000 deaths by acquired immune deficiency syndrome (AIDS) worldwide in the countries reporting data (notably, the United States and China are not included in the reported data) (WHO, 2015b). According to the American Social Health Organization, one out of four teens in the United States becomes infected with an STD each year. Number of new Infectious Diseases cases in US

• Number of new tuberculosis cases: 9,582 
• Number of new salmonella cases: 50,634 
• Number of new Lyme disease cases: 36,307 
• Number of new meningococcal disease cases: 556 

• Number of visits to physician offices for infectious and parasitic diseases: 20.2 million
•Number of hospital outpatient department visits for infectious and parasitic diseases: 3.9 million

Why Japan?

STDs are definitely as common in Japan as in any other modern industrial society. In Japan, one of the world’s wealthiest societies, awareness of the risks posed by the disease is almost non-existent among many young people, and yet their sexual behavior is increasingly risky. Condom use in Japanese society is low. HIV is still relatively uncommon in Japan, but the incidence is slowly increasing. While HIV infection rates in Japan remain officially low at around 6,000, experts fear the real total could be higher, and will get a lot worse unless attitudes begin to change to a disease many Japanese believe only foreigners can catch. According to the Shinjuku-based National Institute of Infectious Diseases, reported cases of this ancient scourge of mankind appear to be making a comeback. While 831 cases were reported in 2008, the number declined to 621 in 2010. By the end of October this year, the count was up to 2,037—up from 1,670 for all of 2014. Infectious diseases kill more people worldwide than any other single cause. Between October and December of last year, 257 new cases of HIV infection were reported to the ministry, of whom 241 were Japanese and 16 foreign nationals. Of these, for 216 the source of infection was in Japan, as opposed to 10 overseas. (Sources for the other 31 were uncertain.) Broken down by age segment, the hardest-hit group was those ages 30-39, with 94 cases, followed by 83 cases for ages 20-29, and 59 cases for ages 40-49.

Japan works to address the three major infectious diseases of HIV/AIDS, tuberculosis, and malaria through the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), and thus far has contributed US$1.29 billion to the Global Fund. In addition, Japan carries out efforts to promote organic collaboration with its bilateral support in order to ensure that countermeasures for the three major infectious diseases are implemented effectively in developing countries that are supported by the Global Fund. For HIV/AIDS countermeasures, Japan raises awareness to prevent new infections and disseminates voluntary counseling and testing services. AAR Japan conducts HIV/AIDS-related operations in Lusaka, the capital of Zambia, and its suburbs, where people have been seriously affected by the disease.

JAPANetwork is a great website based in Nagoya set up by volunteers throughout Japan to increase HIV/AIDS awareness.

Major Associations in Japan

• Association for Aid and Relief, Japan
• Japanese Association for Infectious Diseases
• Japan Medical Association
• Juvenile Products Manufacturers Association (JPMA)
• SciDev.Net
• Japan International Cooperation Agency (JICA)
• International Association for Medical Assistance to Travelers

Products Manufacturing Companies for Infectious Diseases and STD in Japan

•  Shigematsu Co., Ltd
• Shionogi
•  ViroQuest
• ViiV Healthcare Ltd.
• Otsuka Pharmaceutical
• Alfresa Holdings Corporation
• Mogi Pharmaceutical Co., Ltd.
• Alfresa Pharma Corporation
• Wakunaga Pharmaceutical
• ARKRAY
• Oncolys BioPharma
• BioReliance (SAFC)
• IDAC Theranostics
• Mochida Pharmaceutical
• Nippon Kayaku

Counseling and Support Services in Japan:

TELL (Tokyo English Life Line)

Gifu AIDS Support (Telephone Counseling and Support Group in Gifu)

Japan HIV Center (Telephone Counseling and Support Group in Nagoya)

JaNP+ (Network for People with HIV/AIDS in Japan)

Life AIDS Project (Social Support for PLWHA)

HEARTY NETWORK (Gay HIV+ Support Group)